The global E-prescribing market size is projected to reach USD 4,017.79 million by 2026 owing to the implementation of e-prescribing software in the electronic health record solutions that simplified prescription filling over the years. E-prescribing or electronic prescribing is a technology substructure that allows physicians and medical practitioners to send computer-based electronically generated prescriptions to a hospital-based or standalone pharmacy. It is also cost-efficient and reduces the chances of medication errors by pharmacists. The market is discussed in details in a recently published report by Fortune Business Insights™ titled, “E-prescribing Market Size, Share & Industry Analysis, By Delivery Mode (Web-based, On-premise), By Prescription Type (Controlled substance, Non controlled Substances) By End User (Hospitals, Physician’s offices, Pharmacies) and Regional Forecast, 2019-2026.” As per this report, the market value was USD 863.64 million in 2018 and is expected to rise at a CAGR of 21.0 % in the forecast duration set between 2019 to 2026.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/e-prescribing-market-102698

List of Players operating in thisMarket include:

• Epic Systems Corporation
• NextGen Healthcare
• Surescripts
• Medical Information Technology, Inc. (MEDITECH)
• Athenahealth
• eClinicalWorks
• Practice Fusion, Inc.
• Cerner Corporation
• Allscripts Healthcare, LLC
• Others

What are the Report Highlights?

The report is based on an in-depth analysis of the market and provides a 360-degree overview of the same. It throws light on significant industry developments, current e-prescribing market trends, and other interesting insights into the market. It discusses factors boosting, repelling, challenging, ad creating opportunities for the market during the forecast period. The report also describes the table of segmentation in detail and mentions the names and figures of the leading segments with their attributed factors. For more information on the report, log on to the company website.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/e-prescribing-market-102698

Market Drivers

Better Medical Record-Keeping Factor with Electronic-Prescription Solutions to Add Impetus to Market

The increasing adoption of e-prescription based electronic health record (EHR) solutions on a global basis is the key factor boosting the e-prescription market growth. Besides this, electronic prescription system offers better medical history records than handwritten prescriptions. It cannot be forged or exploited, thereby adding to the growth of the market in the forthcoming years. Additionally, rising initiatives taken by both public and private healthcare organizations to integrate e prescribing solutions and eliminate the use of adverse drug events (ADEs) and medical errors will also help to aid in the expansion of the market in the forecast period.

Regional Segmentation:

North America Dominating Market with Increasing Digitization in Healthcare Sector

 Based on geographical segmentation, the market is dominated by North America, with a USD 399.61 million e-prescribing market share earned in 2018. Factors responsible for this dominance include the rise in digitalization in the healthcare sector and government-supported reimbursement policies with the flexible regulatory scenario. Additionally, the increasing funding from public and healthy private organizations with integrated adoption of EHR will help this region continue dominating the market in the coming years. On the other side, the market in Asia Pacific will witness exponential growth on account of the rising penetration of players in this region, especially in the emerging economies of China and India. Additionally, the increasing awareness about healthcare facilities and its associated benefits, coupled with the rising prevalence of chronic disorders, will help the market in the Middle East and Africa, witness stable growth.

The global Nebulizer market size is projected to reach USD 1,778.8 million by 2027, exhibiting a CAGR of 8.1% during the forecast period. Increasing prevalence of respiratory disorders around the world will be the prime growth propeller for this market, shares Fortune Business Insights™ in its new report, titled “Nebulizer Market Size, Share & COVID-19 Impact Analysis, By Type (Jet Nebulizer, Ultrasonic Nebulizer, and Mesh Nebulizer) By Modality (Portable, and Table-top) By End User (Hospitals, Clinics, and Homecare Settings), and Regional Forecast, 2020-2027”.

The World Health Organization (WHO) states that respiratory diseases are the foremost cause of death and disability worldwide. According to its estimates, chronic obstructive pulmonary disorder (COPD) afflicts around 65 million and kills 3 million people every year. Similarly, pneumonia also kills millions of people annually and is the leading cause of mortality among children under 5 years of age. Furthermore, WHO data indicates that lung cancer is the deadliest cancer, killing 1.6 million people every year. Nebulizer play a key role in managing these chronic and potentially fatal lung disorders and as the incidence of these disorders grows, the demand for Nebulizer will continue to surge.

Request a Sample Copy of the Research Report:https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/nebulizers-market-100707

The report states that the market value was at USD 909.7 million in 2019. Its other highlights include:

• Valuable insights into the key market drivers, trends, and restraints;
• Exhaustive analysis of the upcoming market opportunities;
• In-depth examination of the impact of the COVID-19 outbreak on the market; and
• Comprehensive study of the regional prospects and competitive dynamics influencing the market.

An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

To get the short-term and long-term impact of COVID-19 on this Market.

Please visit:https://www.fortunebusinessinsights.com/industry-reports/nebulizers-market-100707

Market Opportunity

Rapid Transmission of the COVID-19 Infection to Create Immediate Growth Opportunities

The SARS-CoV-2 infection attacks the respiratory tract and lungs, causing shortness of breath, acute breathing problems, and pneumonia, along with a persistent fever and cough. People with preexisting lung disorders such as asthma are at high risk of contracting the COVID-19 infection. According to the Centers for Disease Control and Prevention (CDC), asthma patients are highly recommended to carry inhalers or portable Nebulizer with them as these devices can efficiently open the lungs and allow them to function normally. In this scenario, the uptake of inhalable drug delivery devices is likely to spike and favor the Nebulizer market growth. The only worry with these devices, as pointed out by the Asthma and Allergy Foundation of America, is their potential to transmit the infection among patients as well as healthcare workers, especially in healthcare facilities. If this issue is addressed, players can capitalize on the current pandemic and expand their presence in the market.

Regional Analysis

Strong Healthcare Infrastructure to Support Market Growth in North America

North America boasted a market size of USD 308.4 million in 2019 and the region is likely to lead the Nebulizer market share during the forecast period. This is chiefly attributable to the presence of a robust healthcare infrastructure and patient-friendly reimbursement policies. In addition to this, escalating number of COVID-19 cases in the US will skyrocket the demand for Nebulizer and inhalers in 2020. Similar trends are expected to be observed in Europe. On the other hand, the market is Asia-Pacific is slated for steady expansion owing to the proliferation of medical device companies and rising prevalence of chronic respiratory disorders.

 The global telerehabilitation market size is poised to rise remarkably in the coming years attributable to the technological advancements in the field of healthcare services in collaboration with information, technology, and communications. Telerehabilitation is a medical service for people preferring to stay at home and avail treatment and services. As per a recent report by Fortune Business Insights, titled, “Telerehabilitation Market Size, Share and Covid-19 Impact Analysis, By Type (Products, Services), By Application (Occupational Therapy, Physical Therapy, Chronic Diseases, and Others), By End-User (Healthcare Facilities and Homecare); and Regional Forecast, 2020-2027,” the market value stood at USD 3.32 billion in 2019 and is expected to rise at a CAGR of 13.4% to reach USD 9.13 billion by 2027. The forecast period is set between 2020 to 2027.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/telerehabilitation-market-103112

As per Fortune Business Insights™, some of the significant players in this market include:

• MIRA Rehab Limited (UK)
• (United States)
• Doctor On Demand, Inc. (United States)
• Care Innovations, LLC. (United States)

• American Well (United States)
• NeoRehab
• Hinge Health, Inc. (United States)
• Koninklijke Philips N.V. (Netherlands)
• Other players

We, at Fortune Business Insights, are offering special analytical reports on various markets impacted by the worldwide pandemic – COVID-19. As the world economy is shaken with most business at halt or generating meagre revenues, the governments are trying to find out measures to cope with this situation. These special reports will help investors to study the impact of coronavirus on various markets and accordingly take strategic decisions for better revenue generation in the coming years.

Click here to get the short-term and long-term impacts of COVID-19 on this Market.

Please visit: 

https://www.fortunebusinessinsights.com/telerehabilitation-market-103112

The Report Answers the Following Questions:

• How fierce is the market competition?
• Which are the leading segments of the market?
• How will virtual consultation augment growth?
• What are the key industry developments and the current trends prevalent in the market?

Drivers & Restraints-

Increasing Geriatric Population Vulnerable to Various Diseases will Promote Growth

Telerehabilitation can address a wide variety of medical services through the means of telecommunication and technology. This is especially helpful in the case of patients residing in remote locations with mobility issues and for the aged population. The increasing geriatric population is a key factor promoting the telerehabilitation market growth. Additionally, a rise in the patient pool for chronic diseases is also set to aid in the expansion of the market in the coming years.

On the flip side, in several nations, telehealth services do not count as a part of the medical treatment and therefore, it becomes a tedious task to avail reimbursement for such services. The lack of or total absence of proper reimbursement policies for telehealth services are likely to cause hindrance to the market growth in the coming years. 

Nevertheless, the additional beneficiaries associated with this service such as audiology, speech and language therapy, neurophysiology that offer advanced medical ailment are likely to create lucrative growth opportunities for the market in the coming years.

The global examination lights market size is set to reach USD 259.6 million by 2026, exhibiting a CAGR of 3.5% during the forecast period. Increasing patient burden on healthcare facilities worldwide will act as the central growth driver for this market in the upcoming decade. The incidence of various kinds of diseases and disorders is rising at a rapid rate around the world. For instance, close to 463 million people were diabetic in 2019, according to the International Diabetes Federation (IDF). By 2045, IDF expects this number to reach 700 million. Similarly, the World Health Organization states that 18.1 million new cancer cases were reported in 2018 and the diseases caused 9.6 million deaths in the same year. Widespread prevalence of these chronic and life-threatening diseases has compelled governments across the globe to increase their healthcare spending. As a result, healthcare infrastructures globally are getting more robust and technologically advanced, making this factor one of the leading examination lights market trends.

For more information in the analysis of this report, visit:

https://www.fortunebusinessinsights.com/industry-reports/examination-lights-market-101944

Leading Players Covered in the Examination Lights Market Report:

• Mach GmbH & Co. KG
• Technomed India
• Steris plc.
• Stryker
• Skytron LLC
• SIMEON Medical GmbH & Co. KG
• Brandon Medical
• Hill-Rom Services Inc.

Request a Sample Copy of Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/examination-lights-market-101944

Fortune Business Insights™, through its report, titled “Examination Lights Market Size, Share & Industry Analysis, By Technology (LED, and Halogen), By End User (Hospitals, Clinics, and Others) and Regional Forecast, 2019-2026”, states that the value of this market stood at USD 197.1 million in 2018. Besides this, the report also provides the following information:

Profiles of the major players in the market;

• Noteworthy industry developments;
• Analysis of the different market segments;
• Research into the market trends, drivers, and restraints; and
• Evaluation of the current and future prospects in the market in general and in regions in particular.

Few Disadvantages of LED Lights to Put Constraints on Growth

Light Emitting Diodes or LEDs are a landmark advancement in lighting technology as these lights are extremely energy-efficient and have a significantly longer shelf-life compared to conventional halogen lights. However, they suffer from a few limitations which may hold back the examination lights market growth. For instance, the performance of LED lights is dependent on ambient temperature. High ambient temperatures may cause overdriving of LEDs and damage the device. To avoid this situation, effective heat-sinking mechanisms need to be deployed. This factor is vital in the healthcare industry as these lights need to function efficiently across different temperatures in a healthcare facility. Furthermore, LEDs are known to cause ‘blue pollution’ since they emit large quantities of blue light, which is the most intense form of visible light, thereby causing greater amount of light pollution. 

The global orthopedic devices market is set to gain traction from the ever-increasing geriatric population across the world. As per a research published in 2015 by the United Health Foundation, every year, more than 300,000 adults belonging to the age group of 65 years and above are estimated to be hospitalized for hip fractures. Besides, around 30% of seniors fall per year. It is further leading to higher number of orthopedic injuries. Fortune Business Insights™ published this information in a recent study, titled, “Orthopedic Devices Market Size, Share & Industry Analysis, By Type (Joint Reconstruction Devices, Spinal Devices, Trauma Devices, Dental Implants, Orthobiologic Devices, Arthroscopy Devices, and Others), By End User (Hospitals, Orthopedic Clinic, Ambulatory Surgical Centers, and Others), and Regional Forecast, 2019-2026.” The study further mentions that the orthopedic devices market size stood at USD 51.33 billion in 2018 and is projected to reach USD 71.67 billion by 2026, thereby exhibiting a CAGR of 4.3% during the forecast period.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/orthopedic-devices-market-102586

Fortune Business Insights™ presents a list of all the companies operating in the orthopedic medical devices market. They are as follows:

• Smith & Nephew
• Stryker
• Zimmer Biomet
• Medical Devices Business Services, Inc. (Johnson & Johnson)
• NuVasive, Inc.
• Medtronic
• Integra LifeSciences
• Wright Medical Group N.V.
• Össur Corporate
• Globus Medical
• Other prominent players

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/orthopedic-devices-market-102586

This Report Answers the Following Questions:

• What are the orthopedic medical devices market trends?
• How many opportunities and challenges would the market come across in the near future?
• What are the growth drivers and barriers that the market is likely to face?
• How many segments are present in the market?
• Which companies would generate the highest share during the forecast period?
• Which region is set to remain dominant?

Drivers & Restraints-

Rising Prevalence of Musculoskeletal Diseases to Drive Growth

The American Academy of Orthopedic Surgeons, a provider of educational programs for allied health professionals and orthopaedic surgeons, published a report that affirms that every year in the Unites States alone, approximately 6.8 million patients suffering from several orthopedic injuries come to medical attention. It proves that the rising prevalence of orthopedic injuries and musculoskeletal diseases is further resulting in agonizing physical pain and limited mobility. It is expected to propel the orthopedic devices market growth during the forthcoming years. However, the surgical procedure is very expensive in nature. It may hamper the growth of the market.

Segment-

Joint Reconstruction Segment to Lead Backed by Increasing Number of Surgical Procedures

Based on type, the market is grouped into joint reconstruction devices, dental implants, trauma devices, spinal devices, orthobiologic devices, arthroscopy devices, trauma devices, and others. Out of these, in 2018, the joint reconstruction segment held 35.8% in terms of orthopedic devices market share and is anticipated to lead the market throughout the forecast period. This growth is attributable to the rising number of procedures, namely, extrementies and shoulder reconstructions, hip and knee replacements, and other similar procedures associated with joints. The arthroscopy devices segment is likely to expand at fast pace owing to the increasing emergence of novel products and upsurging cases of soft tissue injuries related to sports.

According to the World Bank, approximately 84% populace in Germany depend on Internet and around 75% populace in the U.S. are subscribers of the Internet, which augments the global ePharmacy market growth. Fortune Business Insights states that the global ePharmacy market is projected to reach US$ 177,794.9 Mn by 2026, thereby exhibiting an impressive CAGR of 17.3% during the forecast period (2019-2026). The company further states that the global market was valued at US$ 49,727.7 Mn in 2018. According to a published report by Fortune Business Insights, titled, “ePharmacy: Global Market Analysis, Insights and Forecast, 2019-2026,” the global ePharmacy market will witness notable growth during the forecast period due to the technological advancements based on artificial intelligence.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/epharmacy-market-100238

Fortune Business Insights has profiled some of the prominent market players operating in the global ePharmacy market. They are as follows:

• DocMorris
• CVS Health Corporation
• Express Script Holding Company
• Walgreen Co.
• Optum Rx, Inc.
• Giant Eagle, Inc.
• Walmart Stores, Inc.
• Rowland Pharmacy
• The Kroger Co.
• Other players

Increasing Adoption of E-commerce Websites to Favor Growth in Asia Pacific

Geographically, the global ePharmacy market is grouped into Asia Pacific, North America, the Middle East and Africa, Europe, and Latin America. Out of these regions, North America is expected to remain in the leading position in the global ePharmacy market during the forecast period. The growth is attributed to the rapid shift of consumers towards online retailers from offline pharmacies. Also, increasing usage of smartphones and high speed of the Internet are expected to aid North America in gaining the highest global ePharmacy market share in the forthcoming years. Furthermore, a rise in geriatric population, increasing online orders, and growing adoption of online platforms will drive the market growth in this region.

Europe and Asia Pacific, on the other hand, are projected to exhibit significantly high CAGR during the forecast period. In Europe, numerous prominent market players have begun offering products at lucrative rates. This will positively impact growth of ePharmacy market in this region. Asia Pacific, on the other hand, has been witnessing higher adoption of e-commerce websites and increasing patient pool. Moreover, the healthcare infrastructure in this region is on the verge of becoming prosperous. All these factors are anticipated to fuel ePharmacy market growth in Asia Pacific in the coming years.

Some major points from Table of Content:

1. Introduction
   • Research Scope
   • Market Segmentation
   • Research Methodology
   • Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
   • Market Drivers
   • Market Restraints
   • Market Opportunities
4. Key Insights
   • Key Start-ups and Funding Overview
   • Key Industry Developments – Mergers, Acquisitions, and Partnerships, 2018
   • Overview of Regulatory Scenario – Key Countries
   • Key Industry Trends
   • Overview of e-Commerce Penetration – Key Countries

The increasing incidences of lifestyle disorders have led to a rise in the demand of sugar substitutes. According to a report by Fortune Business Insights, titled, “Sugar Substitutes: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 6.35 Bn in 2018. Fortune Business Insights predicts that the market will rise at a CAGR of 6.3%, and reach US$ 10.27 Bn by the end of 2026.  

Browse Complete Report Details:

https://www.fortunebusinessinsights.com/industry-reports/sugar-substitutes-market-100261

Asia Pacific Likely to Witness a Rapid Market Growth Throughout the Forecast Period

Geographically, the Global Sugar Substitutes Market is divided into North America, Latin America, Europe, Asia Pacific, the Middle East and Africa. Amongst these, the developed markets of Western Europe and North America are leading the global sugar substitutes market. In 2018, sugar taxes came into force in several markets.

Some of the Main Key Players Covered in the Report

• Tate & Lyle
• Cargill, Incorporated
• Archer Daniels Midland Company
• Ingredion Incorporated
• Roquette Frères
• The Nutra Sweet Company
• Ajinomoto Co., Inc.
• JK Sucralose Inc.
• DowDuPont
• Pure Circle Limited

This in turn, has initiated reformulation in multiple processed food segments. A number of companies are providing less sugar while maintaining the same texture and taste of actual sugar. Furthermore, Asia Pacific and the Middle East and Africa are anticipated to witness rapid growth of sugar substitute market above the global average.

Reduction in the consumption of sugar is likely to occur due to the fact that the manufacturers are provoked by the global food and beverage industry to not use sugar in beverages, bakery, infant nutrition, and even breakfast cereals. The reduction of sugar has become more like a norm rather than a trend nowadays, as it aligns positively with the purchasing patterns of the consumers.

The largest segment that has been intensively adopting reduction of sugar the most is beverages. Also, governments and other regulatory bodies have been pressurizing the populace to check their sugar consumptions regularly as too much sugar in one’s system is harmful for health.

Natural Sweeteners are Anticipated to Grow Faster than Artificial Sweeteners

Synthetic sugar alternatives, namely, aspartame, acesulfate potassium, and saccharine have been dominating the global sugar substitutes market due to a rise in their demand from developed markets and also due to vigorous consumption patterns. But, natural sweeteners such as monk fruit and stevia are projected to become more popular than the artificial ones. Roquette Frères, a French-based company has already started working on producing natural sweeteners. It has launched Nutriose, a soluble plant-based fibre for food and nutrition which acts as a reliable sugar substitute.

In the report, Fortune Business Insights has briefed that an increasing emphasis on clinical trials of thrombin has boosted the global market and it is estimated to expand at a CAGR of 4.1%. As of 2018, The Global Thrombin Market was valued at US$ 535.0 Mn and the forecasted CAGR means that this market will be valued at around US$ 738.7 Mn by the end of 2025.

Browse Complete Report Details:

https://www.fortunebusinessinsights.com/industry-reports/thrombin-market-100170

The Global Thrombin Market is supported by the rising rate of thrombosis among individuals, all around. The fatal nature of thrombosis and use of thrombin to trump thrombosis is emphasized in Fortune Business Insights’ latest report, titled “Thrombin Market: Global Analysis, Insights and Forecasts, 2019-2026.”

Widespread Applications of Thrombin to Boost Global Market

Thrombin has come a long way from its conventional use to stop bleeding in small cuts on body parts. Now, thrombin plays a major role in most of the surgeries, worldwide. The clinical efficiency of thrombin has led to its widespread use in the healthcare industry, a key factor enabling growth in the global thrombin market. Thrombin is vastly effective in facilitating surgical hemostasis. Over the years, human thrombin was replaced with bovine thrombin, due to its increased efficiency in surgical procedures.

The Global Parkinson’s Disease Drugs Marketis likely to grow in the coming years due to recent advances in molecular data that has contributed to genome sequencing. According to a report published by Fortune Business Insights, titled “Parkinson’s Disease Drugs Market: Global Market Analysis, Insights, and Forecast, 2018 to 2026,” the market will be valued at US$ 8,383.2 Mn by the end of 2026

Browse Complete Report Details:

https://www.fortunebusinessinsights.com/industry-reports/parkinson-s-disease-drugs-market-100655

Fortune Business Insights states that the market was valued at US$ 4,500.0 Mn in 2018 and is likely to exhibit a CAGR of8.1 in the forecast period.

Parkinson’s Disease Drugs Marketis likely to expand with the highest CAGR, due to an increasing patient pool and favorable reimbursement policies in this region, in the forecast period. The report provides detailed market analysis and exclusive insights for the global Parkinson’s Disease Drugs Market.

Fortune Business Insights segments the market based on various factors in this report. Besides this, Fortune Business Insights has labeled out leading market players

The Global Wound Care Devices Market is expected to rise at a healthy CAGR of 5.1% between 2017 and 2025 as per a new report by Fortune Business Insights. Fortune Business Insights in a report, titled “Wound Care Devices Market: Global Market Analysis, Insights and Forecast, 2018-2025” provides insights on factors enabling growth in the market. As per the report, the market was valued at US$ 1994.8 Mn in 2017 and is projected to reach a valuation of US$ 2949.2 Mn by 2025.

Browse Complete Report Details:

https://www.fortunebusinessinsights.com/industry-reports/wound-care-devices-market-100388

Hyperbaric Oxygen Therapy to Witness Considerably High Demand

In terms of product, hyperbaric oxygen therapy offers several clinical benefits for the treatment of necrotizing and hard-to-heal tissue wounds. Considering this factor, the segment is expected to witness high demand among wound care dressings and devices. Moreover, it covered a share of 7% in the global market in the year 2017.